NICE calls for more research into cannabis-based medicinal products

NICE has published draft recommendations on the use of cannabis-based medicinal products following a comprehensive evaluation of their clinical and cost-effectiveness. Additionally, NHS England has published a review looking at the barriers to prescribing cannabis-based medicinal products where it is safe and clinically appropriate. The review highlights that the lack of evidence about the long term safety and effectiveness of medicinal cannabis has weighed heavily on prescribing decisions and recommends two clinical trials be set up. NICE’s fast-tracked guidance follows the re-classification of these products last year to allow specialist doctors to prescribe them where the clinical needs of patients cannot